Sur­pris­ing Wall Street, Rea­ta un­veils pos­i­tive piv­otal da­ta on Friedre­ich’s atax­ia drug

Days af­ter Rea­ta Phar­ma­ceu­ti­cals un­teth­ered it­self from its part­ner­ship with Ab­b­Vie, the Texas-based drug de­vel­op­er is off to the reg­u­la­tors with pos­i­tive piv­otal da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.